NAVEGLITAZAR SODIUM
UNII 9EPC7SXH23

Substance Identification & Data

This profile provides standardized clinical and technical data for Naveglitazar Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9EPC7SXH23.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 477981-15-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9EPC7SXH23
CAS Registry Number
477981-15-0
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NAVEGLITAZAR SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C25H25O6.Na
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QRZVPGNFLXIZON-JIDHJSLPSA-M
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C([C@H](Cc1ccc(cc1)OCCCOc2ccc(Oc3ccccc3)cc2)OC)([O-])=O.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Naveglitazar Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

NAVEGLITAZAR SODIUM

Systematic Nomenclature

(2S)-2-METHOXY-3-(4-(3-(4-PHENOXYPHENOXY)PROPOXY)PHENYL)PROPANOATE SODIUM
BENZENEPROPANOIC ACID, .ALPHA.-METHOXY-4-(3-(4-PHENOXYPHENOXY)PROPOXY)-, SODIUM SALT (1:1), (.ALPHA.S)-

Technical Codes

LY-519818 SODIUM